Model-organism genomics in veterinary parasite drug-discovery.
A recent article about genomic filtering highlights exciting new opportunities for antiparasitic drug discovery resulting from major advances in genomic technologies. In this article, we discuss several approaches in which model-organism genomics and proteomics could be applied to the identification and validation of novel targets for antiparasitic drug discovery in veterinary medicine.
Gilleard
John S
JS
Division of Infection and Immunity, Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow, Glasgow, UK, G61 1QH.
Woods
Debra J
DJ
Dow
Julian A T
JA
D000818:Animals; D000977:Antiparasitic Agents / Q000494:pharmacology*; D017173:Caenorhabditis elegans / Q000235:genetics / Q000378:metabolism; D004331:Drosophila melanogaster / Q000235:genetics / Q000378:metabolism; D015195:Drug Design; D023281:Genomics; D006801:Humans; D010597:Pharmacogenetics; D040901:Proteomics
D000977:Antiparasitic Agents